Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
With India home to the worlds second-largest population of people living with type-2 diabetes, this launch marks a strategic expansion for Novo Nordisk and strengthens its GLP-1 portfolio, which also includes obesity-focused therapies like Wegovy
It should also include the date it was written, as a Letter of Medical Necessity is typically valid for 12 months
e61-e68
The FDA is also monitoring the availability of other GLP-1 medications, including dulaglutide and liraglutide, which remain in shortage
US$ 27.67
US$ 24.69
US$ 24.49
US$ 28.13
